Abstract
There are no recommendations concerning preoperative management of primary immunodeficiency patients in cases of emergency or planned surgery in relation to risk of hepatitis type B virus infection. To assess if immunodeficient patients regularly supplemented with immunoglobulins are protected against hepatitis B. IgG, IgM and IgA total levels and anti-HBs level were estimated in adult patients with primary humoral immunodeficiency before and after immunoglobulins supplementation according to a standardized schedule. Serum IgG and anti-HBs level significantly increased after immunoglobulin supplementation. Anti-HBs titer increased in all cases over 100 IU/L regardless of initial total IgG serum value, reaching a highly protective level. There was no correlation between increase in concentration of IgG (ΔIgG) versus Δanti-HBs in the studied patients. Patients with primary hypogammaglobulinemia supplemented with immunoglobulin are protected against hepatitis type B.
Similar content being viewed by others
Abbreviations
- IVIG:
-
Intravenous immunoglobulin
- PID:
-
Primary immunodeficiency
- HBs:
-
Surface antigen of hepatitis type B
- CVID:
-
Common variable immunodeficiency
References
Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722–728
International Union of Immunological Societies (1999) Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118:1–28
Riminton DS, Limaye S (2004) Primary immunodeficiency diseases in adulthood. Int Med J 34:348–354
Meheus A (1998) Control of hepatitis B in central and eastern Europe (CEE) and the Newly Independent States (NIS): recommendations of the October 1996 meeting in Siófok, Hungary. Vaccine 16:S99–S103
Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic Criteria for Immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190–197
Seemanova E, Passarge E, Beneskova D et al (1985) Familial microcephaly with normal intelligence, immunodeficiency, and risk for lymphoreticular malignancies: a new autosomal recessive disorder. Am J Med Genet 20:639–648
Daily J, Werner B, Soiffer R, Fingeroth JIGIV (1998) A potential role for hepatitis B prophylaxis in the bone marrow peritransplant period. Bone Marrow Transplant 21:739–742
Zanetti AR, Mariano A, Romano L et al (2005) Long-term immunogenecity of hepatitis B vaccination and policy for booster: an Italian multicenter study. Lancet 366:1379–1384
Knezevic-Maramica I, Kruskall M (2003) Intravenous immune globulins: an update for clinicians. Transfusion 43:1460–1480
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Joanna, G., Slawomir, Ż., Barbara, R. et al. Does the proper intravenous immunoglobulin substitution in primary immunodeficiency protect against HBV infections?: a description of a case series. Med Microbiol Immunol 197, 325–328 (2008). https://doi.org/10.1007/s00430-008-0075-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-008-0075-4